# OnCo record ranok-therapeutics-hangzhou (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/ranok-therapeutics-hangzhou/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "ranok-therapeutics-hangzhou" ;
  schema:name "Ranok Therapeutics (Hangzhou)"@en ;
  schema:alternateName "Ranok Therapeutics (Hangzhou) Co., Ltd."@en, "Ranok Therapuetics Co. Ltd."@en ;
  schema:description "Ranok Therapeutics (Hangzhou) is a China-based biotechnology company running 2 late-stage cancer trials of RNK08954-01 and RNK05047 in sarcomas and diffuse large B-cell lymphoma."@en ;
  schema:url <https://onco.cc/companies/ranok-therapeutics-hangzhou/>, <https://www.ranoktherapeutics.com/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://www.ranoktherapeutics.com/>, <https://clinicaltrials.gov/search?lead=Ranok%20Therapeutics%20(Hangzhou)%20Co.%2C%20Ltd.> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "CN" ;
  onco:cancers <https://onco.cc/cancers/sarcoma/>, <https://onco.cc/cancers/dlbcl/> ;
  onco:drugs <https://onco.cc/drugs/rnk05047/> ;
  onco:trials <https://onco.cc/trials/nct06667544/>, <https://onco.cc/trials/nct07441174/> .